BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:10 PM
 | 
Aug 02, 2007
 |  BC Extra  |  Clinical News

Genzyme's Mozobil meets primary endpoint

GENZ said Mozobil plerixafor plus granulocyte colony stimulating factor (G-CSF) met the primary endpoint of a significant increase in the number of cells collected for transplant vs. G-CSF plus placebo in...

Read the full 136 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >